Tension-free-vaginal-tape-obturator (TVTO) Versus Tension-free-vaginal-tape-Secur (TVTS) for Treatment of SUI
Launched by WESTERN GALILEE HOSPITAL-NAHARIYA · Jul 11, 2011
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with USI who underwent TVTS or TVTO procedure, more than 6 months ago
- Exclusion Criteria:
- • Women who have not undergone TVT procedure
About Western Galilee Hospital Nahariya
Western Galilee Hospital-Nahariya is a leading medical institution located in Israel, dedicated to providing high-quality healthcare services and advancing medical research. As a prominent clinical trial sponsor, the hospital focuses on innovative therapeutic developments across various medical fields, aiming to enhance patient outcomes through rigorous scientific inquiry. With a commitment to ethical standards and patient safety, Western Galilee Hospital-Nahariya collaborates with multidisciplinary teams of healthcare professionals and researchers to facilitate cutting-edge clinical trials that contribute to the advancement of medical knowledge and the improvement of treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nahariya, , Israel
Rishon Lezion, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials